Mixed-Mode Chromatography for Antibody Polishing: Resin Selection, Method Development, and HCP Clearance Optimization

November 2026 18 min read Bioprocess Engineering

Key Takeaways

Contents

  1. What Is Mixed-Mode Chromatography?
  2. Three Interaction Mechanisms in Multimodal Resins
  3. Commercial Mixed-Mode Resins for mAb Polishing
  4. How to Choose Between Flow-Through and Bind-Elute Mode
  5. pH-Conductivity DOE Screening for Method Development
  6. Clearing Problematic HCPs: PLBL2, Cathepsins, and Clusterin
  7. Scale-Up and Process Economics
  8. Frequently Asked Questions

Mixed-mode chromatography (also called multimodal chromatography) has become the go-to polishing technology for monoclonal antibody purification when conventional ion exchange alone cannot meet HCP specifications. By combining two or more interaction mechanisms on a single ligand, multimodal resins achieve selectivity that neither IEX nor HIC can deliver independently. This article is a practical development guide for bioprocess engineers implementing mixed-mode chromatography for mAb polishing. It covers the three major interaction mechanisms, compares seven commercial resins head-to-head, walks through DOE-based pH-conductivity screening, and explains how to clear the problematic host cell proteins that persist through Protein A capture.

What Is Mixed-Mode Chromatography?

Mixed-mode chromatography uses ligands that exploit two or more non-covalent interactions simultaneously, such as electrostatic attraction plus hydrophobic contact, or ionic interaction plus hydrogen bonding. Unlike single-mode IEX or HIC, which separate proteins along one physicochemical axis, multimodal resins create a two-dimensional selectivity landscape. This orthogonal separation power is what makes mixed-mode chromatography particularly effective for antibody polishing, where the remaining impurities after Protein A capture share similar charge profiles with the product.

In a typical three-step mAb platform (Protein A capture, followed by two polishing steps), the polishing train removes residual HCPs to below 100 ppm, clears aggregates to below 1-2%, and reduces leached Protein A to below 10 ng/mg. Single-mode CEX or AEX polishing handles most impurities, but a subset of problematic HCPs co-purify because their charge properties overlap with the mAb at the operating pH. Mixed-mode chromatography adds hydrophobic or hydrogen-bonding selectivity to break these co-elution patterns.

The technology is mature: as of 2026, seven major multimodal resin families are commercially available from Cytiva, Thermo Fisher, Bio-Rad, and Pall/Cytiva, with bead sizes from 34 to 80 micrometers. Published applications range from flow-through HCP polishing to bind-elute aggregate separation and bispecific antibody purification.

Three Interaction Mechanisms in Multimodal Resins

All commercial mixed-mode chromatography resins for antibody polishing rely on one of three primary interaction combinations. Understanding which mechanism a resin uses determines how it binds impurities, how pH and conductivity control selectivity, and whether the step should run in flow-through or bind-elute mode.

Ionic + Hydrophobic (Capto adhere, POROS Caprylate) Resin bead N+ Hydrophobic HCP (impurity) Charge HIC Control levers: pH toggles charge Salt modulates both Resins: Capto adhere ImpRes Capto MMC ImpRes POROS Caprylate Nuvia aPrime 4A Ionic + H-Bonding (CHT ceramic hydroxyapatite) Ca2+ sites PO4 groups Ca2+ PO43- Leached Protein A Ca2+ coord. H-bond Control levers: Phosphate elutes Ca2+ site NaCl elutes PO4 site Resins: CHT Type I (40 um) CHT Type II (40 um) Bio-Rad XT (80 um) Ionic + Thiophilic (MEP HyperCel) Resin bead S Thioether IgG Fc (product) Thiophilic Ionic Control levers: Low pH binds (capture) Neutral pH elutes Resins: MEP HyperCel HEA HyperCel PPA HyperCel
Figure 1. Three mixed-mode interaction mechanisms used in commercial multimodal resins for antibody polishing. Each panel shows the primary dual-interaction pair, the control levers (pH, salt, phosphate), and the commercial resins in that category.
Diagram showing three panels: ionic plus hydrophobic interaction for Capto adhere and POROS Caprylate resins, ionic plus hydrogen bonding for CHT ceramic hydroxyapatite, and ionic plus thiophilic interaction for MEP HyperCel. Each panel illustrates the ligand structure, how it interacts with impurity or product proteins, and the pH and salt control levers.

Ionic + hydrophobic

This is the most widely used mixed-mode chromatography mechanism for mAb polishing. The ligand carries a charged group (quaternary amine for AEX, carboxyl or sulfonate for CEX) coupled with an aromatic or aliphatic hydrophobic moiety. Selectivity is tuned by adjusting pH (which modulates charge interactions) and conductivity (which modulates both charge shielding and hydrophobic exposure). Capto adhere ImpRes (multimodal AEX), Capto MMC ImpRes (multimodal CEX), POROS Caprylate (hydrophobic weak CEX), and Nuvia aPrime 4A (hydrophobic AEX) all fall in this category.

Ionic + hydrogen bonding

Ceramic hydroxyapatite (CHT) is a crystalline form of calcium phosphate that provides two independent binding sites: positively charged calcium ions that coordinate with acidic protein residues and phosphate groups, and negatively charged phosphate clusters that bind basic protein residues through electrostatic and hydrogen-bonding interactions. Phosphate buffer concentration controls calcium-site binding, while NaCl concentration controls phosphate-site binding. CHT is particularly effective at removing leached Protein A (which co-elutes from Protein A capture columns) and aggregates, and it is the only mixed-mode chromatography resin with a fundamentally different matrix material (ceramic vs. agarose or polymer).

Ionic + thiophilic

MEP HyperCel uses a 4-mercapto-ethyl-pyridine ligand that binds immunoglobulins through thiophilic and ionic interactions at low pH (4.0-5.0) and releases them at neutral pH. It was originally developed as a Protein A alternative for antibody capture, and its binding mechanism mimics the Fc-region interaction of Protein A. HEA and PPA HyperCel are related resins using aminohexyl and phenylpropylamine ligands for charge-induction polishing.

Commercial Mixed-Mode Resins for mAb Polishing

Seven commercially available multimodal resin families cover the three interaction mechanisms described above. The table below compares them on the parameters that matter most during resin screening: interaction type, operating mode, bead size, typical dynamic binding capacity, and primary application in the mAb polishing context.

Table 1. Commercial mixed-mode chromatography resins for mAb polishing (as of 2026).
Comparison of commercial multimodal resins for antibody polishing
Resin Vendor Interaction type Typical mode Bead size (um) DBC (mg/mL) Primary application
Capto adhere ImpRes Cytiva Multimodal AEX Flow-through or B/E ~40 80-200 (FT load) HCP, aggregate, leached ProA clearance
Capto MMC ImpRes Cytiva Multimodal CEX Bind/elute ~40 30-55 Charge variant separation, bispecific purification
POROS Caprylate Thermo Fisher Hydrophobic weak CEX Flow-through 50 100-200 (FT load) HCP clearance (PLBL2), aggregate removal
CHT Type I Bio-Rad Ionic + H-bonding Bind/elute 40 25-45 Leached ProA, aggregate, DNA removal
MEP HyperCel Pall/Cytiva Thiophilic + ionic Bind/elute 80 20-35 ProA alternative capture, Fc-binding polishing
Nuvia aPrime 4A Bio-Rad Hydrophobic AEX Flow-through or B/E 55 60-120 (FT load) HCP and aggregate clearance
HEA HyperCel Pall/Cytiva Charge induction Bind/elute 80 25-40 Charge variant polishing

DBC values for flow-through resins represent the maximum mAb load at which impurity clearance specifications are still met. This is fundamentally different from bind-elute DBC (measured at 10% product breakthrough) and is typically 2-5 times higher because the product passes through while only impurities bind.

When selecting resins for screening, start with the impurity to be cleared. If the dominant remaining impurity after Protein A is HCP (especially problematic species like PLBL2), prioritize Capto adhere ImpRes and POROS Caprylate in flow-through mode. If the primary challenge is aggregate removal with leached Protein A clearance, CHT is the established choice. For charge-variant resolution or homo/heterodimer separation in bispecific antibody purification, Capto MMC ImpRes in bind-elute mode offers the widest operating window. Read more about HCP reduction strategies across the full downstream train.

How to Choose Between Flow-Through and Bind-Elute Mode for Mixed-Mode Polishing

The choice between flow-through and bind-elute mode is the single most consequential decision in mixed-mode chromatography method development, because it determines loading capacity, buffer consumption, cycle time, and which impurities can be cleared.

Flow-through mode loads the mAb under conditions where the product passes through the column while HCPs, aggregates, DNA, and leached Protein A bind to the resin. The mAb is collected in the flowthrough fraction with no elution step. Because loading is limited by impurity binding capacity rather than product binding capacity, flow-through loading densities for mixed-mode chromatography resins typically reach 80-200 mg mAb per mL of resin, 3-5 times higher than bind-elute. This translates directly to smaller columns, less buffer, and shorter cycle times.

Bind-elute mode loads the mAb at conditions where both product and impurities bind, then selectively elutes the product away from impurities using a pH, salt, or pH-salt gradient. Bind-elute DBC for multimodal resins is typically 25-55 mg/mL. The advantage is finer selectivity control: gradient elution can resolve charge variants, separate aggregates from monomers, and even split homo- from heterodimers in bispecific antibody purification. The trade-off is lower loading, more buffer, and longer cycle times.

Table 2. Flow-through vs. bind-elute mode for mixed-mode chromatography polishing.
Decision matrix: flow-through vs bind-elute in mixed-mode chromatography
Parameter Flow-through Bind-elute
Typical mAb loading (mg/mL resin) 80-200 25-55
Primary impurity targets HCPs, aggregates, DNA, leached ProA Charge variants, aggregates, HCPs
Selectivity control pH and conductivity of load buffer pH, conductivity, gradient slope
Buffer consumption (CV/cycle) 5-10 15-25
Cycle time 1-3 h 3-6 h
Column size (relative) 1x (smallest) 3-5x
Best for Platform polishing after ProA Charge-variant resolution, bispecifics

Decision rule. Start with flow-through mode if the primary objective is HCP and aggregate clearance without charge-variant resolution. Flow-through mixed-mode chromatography should be the default for platform mAb polishing because it offers the highest productivity and simplest operation. Switch to bind-elute only when (1) charge-variant specification requires gradient resolution, (2) bispecific purification demands separation of product-related species, or (3) flow-through screening fails to meet the HCP specification at any pH-conductivity condition tested.

pH-Conductivity DOE Screening for Method Development

Successful mixed-mode chromatography development requires screening the two-dimensional pH-conductivity space to find the operating point that maximizes impurity clearance while maintaining high mAb recovery. A design of experiments (DOE) approach is far more efficient than one-factor-at-a-time screening because pH and conductivity interact: the optimal pH depends on the conductivity, and vice versa.

Recommended DOE design

For a two-factor screen (pH and conductivity), a central composite design (CCD) with 11 runs (4 factorial + 4 axial + 3 center points) or a definitive screening design (DSD) with 13 runs efficiently maps the response surface. If additional factors are relevant (residence time, load density, temperature), a DSD with 5 factors in 13 runs captures main effects and two-factor interactions in one experiment.

Run the screening on small-scale columns (0.5-1 mL, such as Atoll or MediaScout prepacked columns) or in 96-well filter plates using 50-200 uL resin per well. Condition each column or well with the specific pH-conductivity buffer from the DOE design matrix, then load the Protein A eluate (after pH adjustment and buffer exchange if needed) and collect the flowthrough. Analyze each run for HCP by ELISA, aggregates by SEC-HPLC, and mAb concentration by A280 or Protein A HPLC. You can set up the full experimental matrix with the BioProcess Tools DOE Generator, which supports CCD and DSD designs with custom factor ranges.

Figure 2. pH-conductivity selectivity map for a representative multimodal AEX resin (e.g. Capto adhere ImpRes) in flow-through mode. Bubble size represents HCP clearance (log reduction value, LRV), and color represents mAb recovery. The green zone (pH 6.5-7.5, 5-15 mS/cm) balances high HCP clearance with acceptable recovery for most mAbs.
Bubble chart showing pH on the x-axis from 5.5 to 8.0 and conductivity on the y-axis from 2 to 30 millisiemens per centimeter. Larger bubbles indicate higher HCP clearance. The optimal region is between pH 6.5 and 7.5 at 5 to 15 millisiemens per centimeter.

Worked Example: Flow-Through Polishing DOE for a CHO mAb

Objective: Develop a flow-through mixed-mode chromatography step using Capto adhere ImpRes to polish a CHO-derived IgG1 after Protein A capture. Target: HCP < 50 ppm, aggregates < 1.0%, recovery > 90%.

Starting material: Protein A eluate, pH adjusted to 7.0, 200 ppm HCP, 2.5% aggregates, 15 ng/mg leached Protein A.

DOE design: Central composite design, 2 factors:

Results (best conditions): pH 7.0, 8 mS/cm

Conclusion: A single flow-through mixed-mode chromatography step met all purity specifications. The total column volume needed for a 2,000 L bioreactor batch producing 10 g/L mAb (20 kg) at 150 mg/mL loading is 20,000 g / 150 mg/mL = 133 L resin, equivalent to a 41 cm diameter column at 100 cm bed height.

Clearing Problematic HCPs: PLBL2, Cathepsins, and Clusterin

Not all host cell proteins are equally difficult to remove. Mixed-mode chromatography is specifically valuable for clearing a subset of problematic HCPs that co-purify with monoclonal antibodies through Protein A capture and persist through conventional single-mode polishing steps. These species pose outsized risk because some are enzymatically active and can degrade the drug product during storage.

Phospholipase B-like 2 (PLBL2) is the most frequently cited problematic HCP in CHO-derived mAb production. PLBL2 (65 kDa) interacts directly with IgG molecules, particularly IgG4 subclass antibodies, forming a complex that survives low-pH Protein A elution. It can degrade polysorbate-80 in the formulation buffer, releasing free fatty acid particles visible to patients. Standard CEX polishing often fails to remove PLBL2 because its pI (6.0-6.5) overlaps with many IgG1 antibodies under typical operating conditions. POROS Caprylate in flow-through mode reduced PLBL2 to below the limit of detection in published case studies, exploiting the hydrophobic component of the mixed-mode interaction that CEX alone cannot provide.

Cathepsin D (45 kDa, pI 5.6-6.2) is a lysosomal protease that can clip mAb hinge regions during hold steps, generating half-antibody fragments. It co-purifies because its charge and hydrophobicity are similar to IgG. Mixed-mode chromatography resins with hydrophobic ligand components retain cathepsin D under conditions where the mAb passes through.

Clusterin (75-80 kDa, pI 5.5-6.0) is a chaperone glycoprotein that binds to aggregated or misfolded proteins, including mAb aggregates. It can carry through Protein A by hitchhiking on mAb-aggregate complexes. Because clusterin is itself associated with aggregates, mixed-mode chromatography steps that remove aggregates (particularly in flow-through mode at slightly acidic pH) co-deplete clusterin.

Lipoprotein lipase (56 kDa) is another polysorbate-degrading enzyme that persists through some Protein A and CEX processes. Like PLBL2, it is a target for mixed-mode flow-through polishing. The addition of a mixed-mode chromatography step to the polishing train typically reduces the total problematic HCP population by 1.0-2.0 log (90-99% removal) beyond what CEX or AEX alone achieves. For a full discussion of HCP clearance strategy across the downstream train, see How to Reduce Host Cell Protein to Regulatory Limits.

Scale-Up and Process Economics

Mixed-mode chromatography scales predictably using the same constant bed-height and linear-velocity rules as single-mode chromatography. The primary economic advantage is that flow-through mixed-mode polishing can replace a two-step polish (e.g. CEX + AEX) with a single step, eliminating one column, one buffer set, and one processing day.

Productivity comparison

Figure 3. Performance comparison of five mixed-mode chromatography resins for mAb polishing under standardized screening conditions (Protein A eluate from a CHO IgG1, load 100 mg/mL in FT mode, 50 mg/mL in B/E mode, pH 7.0, 8 mS/cm). Data represents typical literature and vendor-reported ranges.
Grouped bar chart comparing five mixed-mode resins: Capto adhere ImpRes, POROS Caprylate, Nuvia aPrime 4A, CHT Type I, and Capto MMC ImpRes. Metrics: dynamic binding capacity in milligrams per milliliter, HCP log reduction value, aggregate removal percentage, and mAb recovery percentage.

Economic impact of step elimination

Replacing a conventional two-step polish (CEX bind-elute + AEX flow-through) with a single mixed-mode chromatography flow-through step changes the process economics significantly:

For mAb processes producing 10-20 kg per batch (2,000 L bioreactor at 5-10 g/L), a flow-through mixed-mode chromatography step requires 70-250 L of resin compared to 360-800 L for a bind-elute CEX step. Scale-up from the 0.5-1 mL screening columns to process scale uses the chromatography column sizing calculator with constant bed height (20 cm) and linear velocity (150-300 cm/h).

Design Your pH-Conductivity Screening DOE

Set up a CCD or definitive screening design for mixed-mode chromatography method development. Define pH and conductivity ranges, generate the run matrix, and analyze response surfaces.

Open DOE Generator

Calculate Column Sizing for Scale-Up

Size your mixed-mode chromatography column for process scale. Input loading density, bed height, and linear velocity to determine column diameter and resin volume.

Open Chromatography Calculator

Related tools

Frequently Asked Questions

What is mixed-mode chromatography and how does it differ from single-mode methods?

Mixed-mode chromatography (also called multimodal chromatography) uses ligands that combine two or more interaction mechanisms on a single resin bead, such as ionic plus hydrophobic or ionic plus hydrogen bonding. Unlike single-mode ion exchange or HIC, which rely on one interaction type, mixed-mode resins exploit orthogonal selectivity to separate impurities that co-elute in conventional polishing steps. This makes them particularly effective for clearing problematic host cell proteins like PLBL2 and cathepsins that persist through Protein A capture and single-mode polishing.

Can mixed-mode chromatography replace both IEX and HIC polishing steps?

In some cases, yes. Because mixed-mode resins combine charge and hydrophobic interactions, a single mixed-mode step can clear both charge-variant impurities (typically removed by IEX) and hydrophobic impurities like aggregates and leached Protein A (typically removed by HIC). Published case studies report replacing a two-step IEX plus HIC polish with one mixed-mode step while meeting the same purity specifications, reducing buffer consumption by 30-50% and cycle time by 40%.

Which mixed-mode resin is best for mAb polishing?

There is no universally best resin because selectivity depends on the specific mAb, its impurity profile, and whether you need flow-through or bind-elute mode. For flow-through HCP and aggregate clearance, Capto adhere ImpRes and POROS Caprylate are widely used. For bind-elute separations requiring charge-variant resolution or bispecific purification, Capto MMC ImpRes is a strong starting point. CHT ceramic hydroxyapatite excels at leached Protein A removal. Screen 3-5 candidates against your actual Protein A eluate to find the best fit.

How do you optimize pH and conductivity for mixed-mode chromatography?

Use a design of experiments (DOE) approach to screen pH (typically 5.0-8.0) and conductivity (2-30 mS/cm) simultaneously. A central composite design or definitive screening design with pH and conductivity as continuous factors efficiently maps the selectivity space. Measure HCP clearance, aggregate removal, and mAb recovery as responses. The optimal operating point balances all three, typically at pH 6.5-7.5 and 5-15 mS/cm for flow-through multimodal AEX resins.

What loading capacity can I expect from mixed-mode resins?

Loading capacity varies by resin type and operating mode. In flow-through mode, multimodal AEX resins like Capto adhere ImpRes can handle 80-200 mg mAb per mL of resin because the antibody passes through while impurities bind. In bind-elute mode, dynamic binding capacity is typically 25-60 mg/mL at 4-6 min residence time for multimodal CEX resins. Flow-through mode offers significantly higher productivity because loading is limited by impurity binding rather than product binding.

How does mixed-mode chromatography remove problematic HCPs like PLBL2?

Problematic HCPs like PLBL2 (phospholipase B-like 2) co-purify with mAbs through Protein A because they interact directly with the antibody or co-elute under the low-pH elution conditions. Mixed-mode resins exploit additional selectivity dimensions that conventional IEX cannot access. For example, POROS Caprylate in flow-through mode uses hydrophobic and weak cation exchange interactions to retain PLBL2 while the mAb passes through, reducing PLBL2 from detectable levels to below the limit of detection in a single step.

References

  1. Rupčíková V, Molnár T, Kurák T, Polakovič M. Antibody Aggregate Removal by Multimodal Chromatography. Molecules. 2025;30(11):2363. doi:10.3390/molecules30112363
  2. Jafarzadehchehraghi EA, Akbarzadehlaleh P, Shamsasenjan K. Purification technologies of monoclonal antibodies: chromatographic methods. Adv Pharm Bull. 2025;15(1):27-45. doi:10.34172/apb.43967
  3. Gagnon P. Technology trends in antibody purification. J Chromatogr A. 2012;1221:57-70. doi:10.1016/j.chroma.2011.10.034
  4. Levy NE, Valente KN, Choe LH, Lee KH, Lenhoff AM. Identification and characterization of host cell protein product-associated impurities in monoclonal antibody bioprocessing. Biotechnol Bioeng. 2014;111(5):904-912. doi:10.1002/bit.25158
  5. Gao SX, Zhang Y, Stansberry K, et al. Fragmentation of a highly purified monoclonal antibody attributed to residual CHO cell protease activity. Biotechnol Bioeng. 2011;108(4):977-982. doi:10.1002/bit.22982

Resources & Further Reading